409 related articles for article (PubMed ID: 32675281)
21. Renal protection in hypertensive patients: selection of antihypertensive therapy.
Wenzel RR
Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
[TBL] [Abstract][Full Text] [Related]
22. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
23. Effects of mineralocorticoid receptor antagonists in patients with hypertension and diabetes mellitus: a systematic review and meta-analysis.
Takahashi S; Katada J; Daida H; Kitamura F; Yokoyama K
J Hum Hypertens; 2016 Sep; 30(9):534-42. PubMed ID: 26674759
[TBL] [Abstract][Full Text] [Related]
24. Blood pressure lowering effects of β-blockers as add-on or combination therapy: A meta-analysis of randomized controlled trials.
Guo QH; Zhu ZM; Feng YQ; Lin JX; Wang JG
J Clin Hypertens (Greenwich); 2023 Mar; 25(3):227-237. PubMed ID: 36756690
[TBL] [Abstract][Full Text] [Related]
25. Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials.
Liu Y; Ma X; Zheng J; Jia J; Yan T
BMC Nephrol; 2017 Jun; 18(1):206. PubMed ID: 28666408
[TBL] [Abstract][Full Text] [Related]
26. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
[TBL] [Abstract][Full Text] [Related]
27. Impact of Antihypertensive Agents on Central Systolic Blood Pressure and Augmentation Index: A Meta-Analysis.
McGaughey TJ; Fletcher EA; Shah SA
Am J Hypertens; 2016 Apr; 29(4):448-57. PubMed ID: 26289583
[TBL] [Abstract][Full Text] [Related]
28. Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure--meta-analyses of randomized trials.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2016 Mar; 34(3):373-84; discussion 384. PubMed ID: 26780184
[TBL] [Abstract][Full Text] [Related]
29. Blood pressure lowering efficacy of renin inhibitors for primary hypertension.
Musini VM; Fortin PM; Bassett K; Wright JM
Cochrane Database Syst Rev; 2008 Oct; (4):CD007066. PubMed ID: 18843743
[TBL] [Abstract][Full Text] [Related]
30. Combined blockade of renin-angiotensin-aldosterone system reduced all-cause but not cardiovascular mortality in dialysis patients: A mediation analysis and systematic review.
Li SM; He WB; Chen J; Cai QQ; Huang FF; Zhang K; Wang JF; Liu X; Huang H
Atherosclerosis; 2018 Feb; 269():35-41. PubMed ID: 29258005
[TBL] [Abstract][Full Text] [Related]
31. Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.
Nazarzadeh M; Bidel Z; Canoy D; Copland E; Wamil M; Majert J; Smith Byrne K; Sundström J; Teo K; Davis BR; Chalmers J; Pepine CJ; Dehghan A; Bennett DA; Smith GD; Rahimi K;
Lancet; 2021 Nov; 398(10313):1803-1810. PubMed ID: 34774144
[TBL] [Abstract][Full Text] [Related]
32. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.
Copland E; Canoy D; Nazarzadeh M; Bidel Z; Ramakrishnan R; Woodward M; Chalmers J; Teo KK; Pepine CJ; Davis BR; Kjeldsen S; Sundström J; Rahimi K;
Lancet Oncol; 2021 Apr; 22(4):558-570. PubMed ID: 33794209
[TBL] [Abstract][Full Text] [Related]
33. Update on the management of hypertension: recent clinical trials and the JNC 7.
Moser M
J Clin Hypertens (Greenwich); 2004 Oct; 6(10 Suppl 2):4-13. PubMed ID: 15470293
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
Li EC; Heran BS; Wright JM
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
[TBL] [Abstract][Full Text] [Related]
35. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
[TBL] [Abstract][Full Text] [Related]
36. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
[TBL] [Abstract][Full Text] [Related]
37. [Comparative Efficacy of the Influence of Fixed Combinations of Antihypertensive Drugs That Block the Renin-Angiotensin-Aldosterone System, With Thiazide Diuretics on the Parameters of Ambulatory Blood Pressure Monitoring].
Ostroumova OD; Garelik IA
Kardiologiia; 2016 Dec; 56(12):20-26. PubMed ID: 28290800
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Cardiovascular Events Among Users of Different Classes of Antihypertension Medications: A Systematic Review and Network Meta-analysis.
Wei J; Galaviz KI; Kowalski AJ; Magee MJ; Haw JS; Narayan KMV; Ali MK
JAMA Netw Open; 2020 Feb; 3(2):e1921618. PubMed ID: 32083689
[TBL] [Abstract][Full Text] [Related]
39. Vasoactive drugs for acute stroke.
Blood pressure in Acute Stroke Collaboration (BASC)
Cochrane Database Syst Rev; 2000; (4):CD002839. PubMed ID: 11034772
[TBL] [Abstract][Full Text] [Related]
40. Hypertension control in the elderly.
Neutel JM; Gilderman LI
J Clin Hypertens (Greenwich); 2008 Jan; 10(1 Suppl 1):33-9. PubMed ID: 18174782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
